Literature DB >> 15635498

Adrenal androgens and intracrinology.

Fernand Labrie1.   

Abstract

In postmenopausal women, all estrogens and nearly all androgens are made locally in peripheral target tissues from the inactive adrenal steroid precursor dehydroepiandrosterone (DHEA). In adult men, approximated 50% of androgens are made locally. This new section of endocrinology, which describes the local formation of sex steroids, has been named intracrinology. In fact, all the enzymes required to make androgens and estrogens are expressed in a cell-specific fashion, thus permitting local control of steroid formation and action. The local inhibition of sex steroid formation or action has shown important benefits in the treatment of hormone-sensitive cancers, including significant prolongation of survival and even curing localized disease. On the other hand, exogenous DHEA provides important advantages in postmenopausal women because it compensates for the declining secretion of DHEA by the adrenals with age. The benefits of DHEA include increased bone mineral density, muscle mass, well-being, and libido, as well as beneficial effects against skin atrophy, type 2 diabetes, and obesity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15635498     DOI: 10.1055/s-2004-861547

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  41 in total

1.  Comparison of serum testosterone levels in prostate cancer patients receiving LHRH agonist therapy with or without the removal of the prostate.

Authors:  Seetha Venkateswaran; David Margel; Stanley Yap; Karen Hersey; Paul Yip; Neil Eric Fleshner
Journal:  Can Urol Assoc J       Date:  2012-06       Impact factor: 1.862

Review 2.  Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.

Authors:  William P Harris; Elahe A Mostaghel; Peter S Nelson; Bruce Montgomery
Journal:  Nat Clin Pract Urol       Date:  2009-02

Review 3.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 4.  CYP17A1 inhibitors in castration-resistant prostate cancer.

Authors:  Lissette Gomez; Jason R Kovac; Dolores J Lamb
Journal:  Steroids       Date:  2015-01-03       Impact factor: 2.668

5.  Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.

Authors:  L C Macleod; L J Chery; E Y C Hu; S B Zeliadt; S K Holt; D W Lin; M P Porter; J L Gore; J L Wright
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-03-31       Impact factor: 5.554

6.  Redefining hormone resistance in prostate cancer.

Authors:  Christopher J Hoimes; W Kevin Kelly
Journal:  Ther Adv Med Oncol       Date:  2010-03-01       Impact factor: 8.168

7.  Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men.

Authors:  Guangfu Jin; Jielin Sun; Seong-Tae Kim; Junjie Feng; Zhong Wang; Sha Tao; Zhuo Chen; Lina Purcell; Shelly Smith; William B Isaacs; Roger S Rittmaster; S Lilly Zheng; Lynn D Condreay; Jianfeng Xu
Journal:  Hum Mol Genet       Date:  2012-08-30       Impact factor: 6.150

8.  LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer.

Authors:  Tammy L Romanuik; Gang Wang; Olena Morozova; Allen Delaney; Marco A Marra; Marianne D Sadar
Journal:  BMC Med Genomics       Date:  2010-09-24       Impact factor: 3.063

Review 9.  Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications.

Authors:  Elahe A Mostaghel; Peter S Nelson
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-04       Impact factor: 4.690

Review 10.  Effect of estrogens on skin aging and the potential role of SERMs.

Authors:  Susan Stevenson; Julie Thornton
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.